Cellectar Biosciences Inc (CLRB) announced Loss for first quarter of -$6.60 million
The company's bottom line came in at -$6.60 million, or -$0.14 per share. This compares with -$26.64 million, or -$0.91 per share, last year.
Cellectar Biosciences Inc earnings at a glance (GAAP) :
-Earnings: -$6.60 Mln. vs. -$26.64 Mln. last year.
-EPS: -$0.14 vs. -$0.91 last year.
For comments and feedback: editorial@rttnews.com